Suppr超能文献

遗传性弥漫性胃癌预防性全胃切除术后的结局

[Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer].

作者信息

Pantelis Dimitrios, Lingohr Philipp, Hueneburg Robert, Spier Isabel, Vilz Tim, Lau Jan F, Nattermann Jacob, Aretz Stefan, Strassburg Christian P, Kalff Jörg C

机构信息

Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Bonn.

Medizinische Klinik und Poliklinik I - Allgemeine Innere Medizin, Universitätsklinikum Bonn.

出版信息

Zentralbl Chir. 2020 Feb;145(1):41-47. doi: 10.1055/a-0646-4382. Epub 2018 Aug 1.

Abstract

INTRODUCTION

Prophylactic total gastrectomy is the treatment of choice in patients with germline mutation in the CDH1 gene and therefore high risk for hereditary diffuse gastric cancer (HDGC). Minimally invasive techniques have been established in recent years for treatment of gastric cancer.

METHODS

We report findings with 12 patients with proven CDH1 mutation who underwent multidisciplinary treatment between 2013 and 3/2018 in our centre for hereditary tumour diseases, followed by prophylactic total gastrectomy in our department. Data were collected in a prospective hereditary tumour database.

RESULTS

Open prophylactic total gastrectomy was performed in 5 patients (between 2013 and 2015) and minimally invasive prospective gastrectomy in 7 patients (between 2015 and 2018). The median age of all patients (7 women and 5 men) was 42 (range: 19 - 60) years. The mean operation time was 291 ± 72 minutes (open: 269 ± 70; minimally invasive: 307 ± 75). Perioperative 60-day mortality and anastomotic leakage rate were 0%. In 3 patients, postoperative complications occurred (according to the Clavien-Dindo classification: one each of grades II, IIIa and IVb, respectively), and therefore 25% morbidity. The average postoperative hospital stay was 14.5 ± 6.2 days (open: 16.2 ± 7.9; minimally invasive: 13.3 ± 5.0). In 10 of 12 patients (83%), foci of intramucosal signet ring cell carcinomas were found in the gastric specimen, in 9 patients with multifocal dissemination. There were no cases with advanced carcinomas (≥ pT1b) or lymph node metastases.

CONCLUSION

Patients with suspected high risk for hereditary diffuse gastric cancer should be cared for in a multidisciplinary centre for hereditary tumour diseases. Laparoscopic total gastrectomy is a safe and feasible risk-reducing procedure for patients with CDH1 germline mutation. Therefore, in the absence of contraindications and with available surgical expertise, the minimally invasive operation should be the standard procedure for these patients.

摘要

引言

预防性全胃切除术是患有CDH1基因种系突变且因此患遗传性弥漫性胃癌(HDGC)风险较高患者的首选治疗方法。近年来,微创技术已被确立用于胃癌治疗。

方法

我们报告了12例经证实患有CDH1突变的患者的研究结果,这些患者于2013年至2018年3月在我们的遗传性肿瘤疾病中心接受了多学科治疗,随后在我们科室接受了预防性全胃切除术。数据收集于前瞻性遗传性肿瘤数据库。

结果

5例患者(2013年至2015年期间)接受了开放性预防性全胃切除术,7例患者(2015年至2018年期间)接受了微创性前瞻性胃切除术。所有患者(7名女性和5名男性)的中位年龄为42岁(范围:19 - 60岁)。平均手术时间为291±72分钟(开放性手术:269±70分钟;微创性手术:307±75分钟)。围手术期60天死亡率和吻合口漏率均为0%。3例患者发生了术后并发症(根据Clavien-Dindo分类:分别为II级、IIIa级和IVb级各1例),因此发病率为25%。术后平均住院时间为14.5±6.2天(开放性手术:16.2±7.9天;微创性手术:13.3±5.0天)。12例患者中有10例(83%)在胃标本中发现了黏膜内印戒细胞癌病灶,其中9例为多灶性扩散。没有晚期癌(≥pT1b)或淋巴结转移的病例。

结论

疑似遗传性弥漫性胃癌高风险患者应在遗传性肿瘤疾病多学科中心接受治疗。腹腔镜全胃切除术对于患有CDH1种系突变的患者是一种安全可行的降低风险手术。因此,在没有禁忌症且有可用手术专业知识的情况下,微创手术应成为这些患者的标准手术方式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验